Tearsheet

LakeShore Biopharma (LSB)

Market Price (9/30/2025): $0.4919 | Market Cap: $4.6 Mil
Sector: Health Care | Industry: Biotechnology

LakeShore Biopharma (LSB)

Market Price (9/30/2025): $0.4919
Market Cap: $4.6 Mil
Sector: Health Care
Industry: Biotechnology

Investment Highlights

0			Not profitable at operating income level Op Inc LTMOperating Income, Last Twelve Months is -164 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -24%
1			Debt is significant Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 5020%
2			Yield minus risk free rate is negative ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -3171%

0	Not profitable at operating income level Op Inc LTMOperating Income, Last Twelve Months is -164 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -24%
1	Debt is significant Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 5020%
2	Yield minus risk free rate is negative ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -3171%

Market Valuation

	9/30/25	2024	2023	2022
Share Price CYE	$0.49	$3.46	$5.11
Market Cap CYE ($ Mil)	4.6	32.2	47.6	-
Total Debt ($ Mil)	554.2	414.4	424.5	498.6
Total Cash ($ Mil)	259.9	28.1	246.4	370.1
Enterprise Value ($ Mil)	298.9	446.6	472.1
Valuation Ratios
P/S TTM	0.0	0.1	0.1	0.0
P/EBIT TTM	-0.0	-0.8	-0.1	0.0
P/E TTM	-0.0	-0.7	-0.1	0.0
Sector Ratios
P/S TTM (Sector)	3.7	3.6	4.0	4.5
P/EBIT TTM (Sector)	-1.6	-1.3	-1.4	-1.3
P/E TTM (Sector)	-1.9	-1.5	-1.5	-1.3

	9/30/25	2024
Share Price CYE	$0.49	$3.46
Market Cap CYE ($ Mil)	4.6	32.2
Total Debt ($ Mil)	554.2	414.4
Total Cash ($ Mil)	259.9	28.1
Enterprise Value ($ Mil)	298.9	446.6
Valuation Ratios
P/S TTM	0.0	0.1
P/EBIT TTM	-0.0	-0.8
P/E TTM	-0.0	-0.7
Sector Ratios
P/S TTM (Sector)	3.7	3.6
P/EBIT TTM (Sector)	-1.6	-1.3
P/E TTM (Sector)	-1.9	-1.5

Stock Price
Market Cap

Return (1M):

Business Description

LakeShore Biopharma Co., Ltd, a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. Show more

Price Returns Compared

Expand for Detailed View

	2020	2021	2022	2023	2024	2025	Total [1]
Returns
LSB Return	-	-	-	-	-32%	-82%	-88%
Peers Return	75%	-16%	-34%	-21%	-51%	47%	-45%
S&P 500 Return	16%	27%	-19%	24%	23%	13%	106%

[1] Cumulative total returns since the beginning of 2020
[2] Peers: VRTX, EDIT, INFIQ, SRNE, STA.
[3] 2025 data is for the year up to 9/29/2025 (YTD)

Better Bets than LakeShore Biopharma (LSB)

	LSB	Better Performance than LSB
Metric	Value	Industry (Biotechnology)
Op Mgn LTM	-24.4%	ABBV (23.5%), AMGN (23.5%), GILD (37.4%), VRTX (-1.7%), REGN (27.0%)
Total Yield	-3166.6%	ABBV (3.8%), AMGN (7.9%), GILD (7.3%), VRTX (3.6%), REGN (7.9%)

	LSB	Better Performance than LSB
Metric	Value	Sector (Health Care)
Op Mgn LTM	-24.4%	LLY (43.0%), JNJ (24.5%), ABBV (23.5%), UNH (7.3%), ABT (17.4%)
Total Yield	-3166.6%	LLY (2.9%), JNJ (8.0%), ABBV (3.8%), UNH (9.3%), ABT (7.7%)

	LSB	Better Performance than LSB
Metric	Value	All Other Sectors
Op Mgn LTM	-24.4%	NVDA (58.1%), MSFT (45.6%), AAPL (31.9%), GOOGL (32.7%), AMZN (11.4%)
Total Yield	-3166.6%	NVDA (2.0%), MSFT (3.3%), AAPL (3.0%), GOOGL (4.2%), AMZN (3.0%)

Trade Ideas

Select past trade ideas related to LSB and Biotechnology.

Unique Key	Date	Ticker	Company	Category	Trade Strategy	6M Fwd Rtn	12M Fwd Rtn	12M Max DD
LNTH_8312025_Dip_Buyer_High_CFO_Margins_ExInd_DE	08312025	LNTH	Lantheus	Dip Buy	DB \| CFO/Rev \| Low D/EDip Buy with High Cash Flow Margins Buying dips for companies with significant cash flows from operations and reasonable debt / market cap	-7.8%	-7.8%	-8.7%
COO_8312025_Monopoly_xInd_xCD_Getting_Cheaper	08312025	COO	Cooper Companies	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	0.2%	0.2%	-4.6%
WST_8312025_Monopoly_xInd_xCD_Getting_Cheaper	08312025	WST	West Pharmaceutical Services	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	5.9%	5.9%	-1.3%
BMY_7312025_Dip_Buyer_FCFYield	07312025	BMY	Bristol-Myers Squibb	Dip Buy	DB \| FCFY OPMDip Buy with High FCF Yield and High Margin Buying dips for companies with high FCF yield and meaningfully high operating margin	1.9%	1.9%	0.0%
UTHR_7312025_Dip_Buyer_FCFYield	07312025	UTHR	United Therapeutics	Dip Buy	DB \| FCFY OPMDip Buy with High FCF Yield and High Margin Buying dips for companies with high FCF yield and meaningfully high operating margin	57.5%	57.5%	0.0%

Unique Key	Date	Ticker	Company	Category	Trade Strategy	6M Fwd Rtn	12M Fwd Rtn	12M Max DD
LNTH_8312025_Dip_Buyer_High_CFO_Margins_ExInd_DE	08312025	LNTH	Lantheus	Dip Buy	DB \| CFO/Rev \| Low D/EDip Buy with High Cash Flow Margins Buying dips for companies with significant cash flows from operations and reasonable debt / market cap	-7.8%	-7.8%	-8.7%
COO_8312025_Monopoly_xInd_xCD_Getting_Cheaper	08312025	COO	Cooper Companies	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	0.2%	0.2%	-4.6%
WST_8312025_Monopoly_xInd_xCD_Getting_Cheaper	08312025	WST	West Pharmaceutical Services	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	5.9%	5.9%	-1.3%
BMY_7312025_Dip_Buyer_FCFYield	07312025	BMY	Bristol-Myers Squibb	Dip Buy	DB \| FCFY OPMDip Buy with High FCF Yield and High Margin Buying dips for companies with high FCF yield and meaningfully high operating margin	1.9%	1.9%	0.0%
UTHR_7312025_Dip_Buyer_FCFYield	07312025	UTHR	United Therapeutics	Dip Buy	DB \| FCFY OPMDip Buy with High FCF Yield and High Margin Buying dips for companies with high FCF yield and meaningfully high operating margin	57.5%	57.5%	0.0%

See Trefis Trade Ideas for more.

Recent Active Movers

1 Day Top Gainers

#	Ticker	Company	1D Rtn	YTD Rtn
1	WOLF	Wolfspeed	1726.4%	231.8%
2	BQ	Boqii	233.2%	153.9%
3	YCBD	cbdMD	121.2%	-54.0%
4	ENTA	Enanta Pharmaceuticals	91.9%	163.7%
5	JFB	JFB Construction	85.4%
6	TLRY	Tilray Brands	60.9%	39.1%
7	POAI	Predictive Oncology	54.8%	46.3%
8	SCOR	comScore	46.2%	53.3%
9	DWTX	Dogwood Therapeutics	43.3%	217.7%
10	BKKT	Bakkt	42.3%	3.1%

1 Day Top Losers

#	Ticker	Company	1D Rtn	YTD Rtn
1	MLTX	MoonLake Immunotherapeutics	-89.9%	-88.5%
2	KALA	Kala Bio	-89.3%	-70.5%
3	IOBT	IO Biotech	-76.9%	-60.3%
4	JZXN	Jiuzi	-60.3%	-69.5%
5	APLT	Applied Therapeutics	-50.7%	-28.5%
6	MTEK	Maris Tech	-50.6%	-58.9%
7	BIAF	bioAffinity Technologies	-38.6%	-88.1%
8	MTEN	Mingteng International	-38.0%	0.0%
9	BYND	Beyond Meat	-36.1%	-51.6%
10	LRMR	Larimar Therapeutics	-33.7%	-12.7%

1 Week Top Gainers

#	Ticker	Company	1W Rtn	YTD Rtn
1	FTEL	Fitell	1068.4%	-96.0%
2	WOLF	Wolfspeed	886.6%	231.8%
3	WHLR	Wheeler Real Estate Investment Trust	404.4%	-99.7%
4	MNDR	Mobile-health Network Solutions	388.0%	-71.1%
5	QURE	uniQure	329.5%	236.4%
6	NUAI	New Era Energy & Digital	311.7%
7	BQ	Boqii	208.5%	153.9%
8	DVLT	Datavault AI	180.5%
9	DFLI	Dragonfly Energy	132.9%	-76.4%
10	SHFS	SHF	130.9%	-18.7%

1 Week Top Losers

#	Ticker	Company	1W Rtn	YTD Rtn
1	WOK	WORK Medical Technology	-91.5%	-98.5%
2	KALA	Kala Bio	-89.0%	-70.5%
3	MLTX	MoonLake Immunotherapeutics	-88.6%	-88.5%
4	SDM	Smart Digital	-87.5%	-83.8%
5	NRIM	Northrim BanCorp	-76.1%	14.0%
6	IOBT	IO Biotech	-75.5%	-60.3%
7	ZYBT	Zhengye Biotechnology	-74.9%
8	AMBI	Ambipar Emergency Response	-74.0%	-78.8%
9	FGL	Founder	-63.8%	-64.3%
10	BINI	Bollinger Innovations	-63.6%	-100.0%

1 Month Top Gainers

#	Ticker	Company	1M Rtn	YTD Rtn
1	PMI	Picard Medical	13709.5%	13709.5%
2	TNFA	TNF Pharmaceuticals	7529.9%	-95.9%
3	QMMM	QMMM	2749.6%	9228.1%
4	WOLF	Wolfspeed	1757.1%	231.8%
5	EAF	GrafTech International	1199.0%	-24.2%
6	SEGG	Lottery.com	646.7%	-7.9%
7	SLNH	Soluna	435.8%	20.0%
8	PTNM	Pitanium	433.3%
9	NUAI	New Era Energy & Digital	395.6%
10	BREA	Brera	380.3%	3593.8%

1 Month Top Losers

#	Ticker	Company	1M Rtn	YTD Rtn
1	BINI	Bollinger Innovations	-96.1%	-100.0%
2	WOK	WORK Medical Technology	-90.8%	-98.5%
3	CJET	Chijet Motor	-90.3%	-92.7%
4	MLTX	MoonLake Immunotherapeutics	-88.6%	-88.5%
5	YAAS	Youxin Technology	-85.8%	-98.9%
6	ATYR	aTyr Pharma	-85.1%	-78.0%
7	CURX	Curanex Pharmaceuticals	-84.9%	28.8%
8	YYGH	YY	-84.6%	-80.3%
9	NEON	Neonode	-84.6%	-58.7%
10	SDM	Smart Digital	-82.5%	-83.8%

Recent Active Movers

1 Day Top Gainers

#	Ticker	Company	1D Rtn	YTD Rtn
1	WOLF	Wolfspeed	1726.4%	231.8%
2	BQ	Boqii	233.2%	153.9%
3	YCBD	cbdMD	121.2%	-54.0%
4	ENTA	Enanta Pharmaceuticals	91.9%	163.7%
5	JFB	JFB Construction	85.4%
6	TLRY	Tilray Brands	60.9%	39.1%
7	POAI	Predictive Oncology	54.8%	46.3%
8	SCOR	comScore	46.2%	53.3%
9	DWTX	Dogwood Therapeutics	43.3%	217.7%
10	BKKT	Bakkt	42.3%	3.1%

1 Day Top Losers

#	Ticker	Company	1D Rtn	YTD Rtn
1	MLTX	MoonLake Immunotherapeutics	-89.9%	-88.5%
2	KALA	Kala Bio	-89.3%	-70.5%
3	IOBT	IO Biotech	-76.9%	-60.3%
4	JZXN	Jiuzi	-60.3%	-69.5%
5	APLT	Applied Therapeutics	-50.7%	-28.5%
6	MTEK	Maris Tech	-50.6%	-58.9%
7	BIAF	bioAffinity Technologies	-38.6%	-88.1%
8	MTEN	Mingteng International	-38.0%	0.0%
9	BYND	Beyond Meat	-36.1%	-51.6%
10	LRMR	Larimar Therapeutics	-33.7%	-12.7%

1 Week Top Gainers

#	Ticker	Company	1W Rtn	YTD Rtn
1	FTEL	Fitell	1068.4%	-96.0%
2	WOLF	Wolfspeed	886.6%	231.8%
3	WHLR	Wheeler Real Estate Investment Trust	404.4%	-99.7%
4	MNDR	Mobile-health Network Solutions	388.0%	-71.1%
5	QURE	uniQure	329.5%	236.4%
6	NUAI	New Era Energy & Digital	311.7%
7	BQ	Boqii	208.5%	153.9%
8	DVLT	Datavault AI	180.5%
9	DFLI	Dragonfly Energy	132.9%	-76.4%
10	SHFS	SHF	130.9%	-18.7%

1 Week Top Losers

#	Ticker	Company	1W Rtn	YTD Rtn
1	WOK	WORK Medical Technology	-91.5%	-98.5%
2	KALA	Kala Bio	-89.0%	-70.5%
3	MLTX	MoonLake Immunotherapeutics	-88.6%	-88.5%
4	SDM	Smart Digital	-87.5%	-83.8%
5	NRIM	Northrim BanCorp	-76.1%	14.0%
6	IOBT	IO Biotech	-75.5%	-60.3%
7	ZYBT	Zhengye Biotechnology	-74.9%
8	AMBI	Ambipar Emergency Response	-74.0%	-78.8%
9	FGL	Founder	-63.8%	-64.3%
10	BINI	Bollinger Innovations	-63.6%	-100.0%

Peer Comparisons for LakeShore Biopharma

Financials

	LSB	VRTX	EDIT	INFIQ	SRNE	STA	Median
Name	LakeShor.	Vertex P.	Editas M.	Infinity.	Sorrento.	Starton .
Mkt Price	-	395.31	3.52	-	-	-	199.41
Mkt Cap	0.0	101.5	0.3	-	-	-	0.3
Rev LTM	673	11,419	39	-	-	0	356
Op Inc LTM	-164	-199	-161	-	-	-11	-162
FCF LTM	-	3,500	-205	-	-	-	1,647
FCF 3Y Avg	-	1,984	-182	-	-	-	901
CFO LTM	-	3,846	-201	-	-	-	1,823
CFO 3Y Avg	-	2,324	-177	-	-	-	1,073

Growth & Margins

	LSB	VRTX	EDIT	INFIQ	SRNE	STA	Median
Name	LakeShor.	Vertex P.	Editas M.	Infinity.	Sorrento.	Starton .
Rev Chg LTM	-	10.5%	-42.0%	-	-	-	-15.8%
Rev Chg 3Y Avg	-	11.0%	55.3%	-	-	-	33.1%
Rev Chg Q	-	12.1%	597.5%	-	-	-	304.8%
QoQ Delta Rev Chg LTM	-	2.9%	8.6%	-	-	-	5.7%
Op Mgn LTM	-24.4%	-1.7%	-413.4%	-	-	-	-24.4%
Op Mgn 3Y Avg	-	26.5%	-616.5%	-	-	-	-295.0%
QoQ Delta Op Mgn LTM	-	2.0%	164.9%	-	-	-	83.5%
CFO/Rev LTM	-	33.7%	-517.6%	-	-	-	-242.0%
CFO/Rev 3Y Avg	-	22.5%	-538.7%	-	-	-	-258.1%
FCF/Rev LTM	-	30.6%	-526.8%	-	-	-	-248.1%
FCF/Rev 3Y Avg	-	19.2%	-552.8%	-	-	-	-266.8%

Valuation

	LSB	VRTX	EDIT	INFIQ	SRNE	STA	Median
Name	LakeShor.	Vertex P.	Editas M.	Infinity.	Sorrento.	Starton .
Mkt Cap	0.0	101.5	0.3	-	-	-	0.3
P/S	0.0	8.9	7.6	-	-	-	7.6
P/EBIT	-0.0	23.1	-1.3	-	-	-	-0.0
P/E	-0.0	27.9	-1.3	-	-	-	-0.0
P/CFO	-	26.4	-1.5	-	-	-	12.5
Total Yield	-3,166.6%	3.6%	-79.7%	-	-	-	-79.7%
Dividend Yield	0.0%	0.0%	0.0%	-	-	-	0.0%
FCF Yield 3Y Avg	-	2.1%	-61.3%	-	-	-	-29.6%
D/E	94.5	0.0	0.1	-	-	-	0.1
Net D/E	50.2	-0.0	-0.5	-	-	-	-0.0

Returns

	LSB	VRTX	EDIT	INFIQ	SRNE	STA	Median
Name	LakeShor.	Vertex P.	Editas M.	Infinity.	Sorrento.	Starton .
1M Rtn	-	1.1%	37.0%	-	-	-	19.0%
3M Rtn	-	-11.2%	60.0%	-	-	-	24.4%
6M Rtn	-	-18.5%	203.4%	-	-	-	92.5%
12M Rtn	-	-14.6%	1.1%	-	-	-	-6.7%
3Y Rtn	-	36.5%	-71.2%	-	-	-	-17.4%
1M Excs Rtn	-	-1.6%	30.4%	-	-	-	14.4%
3M Excs Rtn	-	-18.6%	52.6%	-	-	-	17.0%
6M Excs Rtn	-	-39.1%	162.2%	-	-	-	61.6%
12M Excs Rtn	-	-30.8%	-12.6%	-	-	-	-21.7%
3Y Excs Rtn	-	-39.2%	-150.7%	-	-	-	-95.0%

Financials

Annual
Quarterly

$ Mil \| FY: 3/31	LTM	2025	2024	2023	2022	2021
Period End	9/30/2023	3/31/2025	3/31/2024	3/31/2023	3/31/2022	3/31/2021
Filing Date	1/22/2024	7/31/2025	8/15/2024	8/15/2023	2/8/2023	8/15/2023
Key Financials
Total Revenue	673	615	573	687	503	257
EBITDA	-158	-49	-369	-77	-67	-117
Operating Income	-164	-44	-268	-105	-86	-122
Net Income	-186	-100	-433	-145	-106	-192
EPS	-27.83	-5.22	-40.54	-23.55	-25.68	-22.61
Growth Rates
Total Revenue Growth	-	7.2%	-16.6%	36.6%	95.7%	-
EBITDA Growth	-	86.8%	-380.0%	-14.3%	42.5%	-
Operating Income Growth	-	83.4%	-155.8%	-21.0%	29.3%	-
Net Income Growth	-	76.9%	-198.0%	-37.2%	44.7%	-
Margins
EBITDA Margin	-23.4%	-7.9%	-64.3%	-11.2%	-13.4%	-45.4%
Operating Income Margin	-24.4%	-7.2%	-46.7%	-15.2%	-17.2%	-47.6%
Net Income Margin	-27.6%	-16.3%	-75.6%	-21.2%	-21.1%	-74.6%
Cash & Debt
Total Cash	260	28	246	370	271	390
Total Debt	554	414	424	499	381	18
Net Debt / (Cash)	294	386	178	129	110	-372
Cash Flows
Net Cash from Operations	-	-121	-295	-182	-174	-247
Free Cash from Operations	-	-139	-339	-240	-472	-351
Returns to Shareholders
Dividends	0	-0	-0	-0	-0	-0
Share Repurchases	-0	-0	-0	-0	-0	-0

$ Mil \| FY: 3/31	2024Q2	2024Q1	2023Q2	2023Q1
Period End	9/30/2023	6/30/2023	9/30/2022	6/30/2022
Filing Date	1/22/2024	8/16/2023	2/8/2023	8/16/2023
Key Financials Quarterly
Total Revenue	97	176	194	205
Ebitda	-100	-62	16	-12
Operating Income	-100	-69	16	-12
Net Income	-105	-70	8	-20
EPS	-11.33	-7.47	-3.16	-5.87
Key Financials TTM
Total Revenue TTM	673	-	-	-
Ebitda TTM	-158	-	-	-
Operating Income TTM	-164	-	-	-
Net Income TTM	-186	-	-	-
Growth Rates Quarterly
Total Revenue Growth	-	-	-	-
EBITDA Growth	-	-	-	-
Operating Income Growth	-	-	-	-
Net Income Growth	-	-	-	-
Margins Quarterly
EBITDA Margin	-103.6%	-35.2%	8.4%	-5.6%
Operating Income Margin	-103.3%	-38.9%	8.4%	-5.7%
Net Income Margin	-108.4%	-39.5%	4.4%	-9.5%
Cash & Debt
Total Cash	260	95	227	-
Total Debt	554	527	462	0
Net Debt / (Cash)	294	432	235	-
Cash Flows Quarterly
FCF from Operations	-	-	-	-
Cash Flows TTM
FCF from Operations TTM	-	-	-	-
Returns to Shareholders Quarterly
Dividends	0	0	0	0
Share Repurchases	-0	-0	-0	-0
Return on Invested Capital (ROIC) Quarterly
ROIC	-13.8%	-9.0%	6.8%	-
Return on Invested Capital (ROIC) TTM
ROIC TTM	-5.6%	-	-	-

Price Behavior

Behavior Stats
Betas Matrix

Price Behavior

Market Price	$0.63
Market Cap ($ Bil)	0.0
First Trading Date	03/17/2023
Distance from 52W High	-92.5%
	50 Days	200 Days
DMA Price	$0.87	$1.70
DMA Trend	down	down
Distance from DMA	-28.1%	-63.1%
	3M	1YR
Volatility	137.0%	129.4%
Downside Capture	16.38	218.19
Upside Capture	-309.01	-83.72
Correlation (SPY)	0.9%	8.6%

LSB Betas & Captures as of 8/31/2025

	1M	2M	3M	6M	1Y	3Y
Beta	0.66	-0.18	0.61	0.60	0.60	-0.07
Up Beta	-0.10	-1.94	-1.15	-0.30	-0.26	-0.23
Down Beta	10.54	8.27	7.04	1.44	1.67	0.17
Up Capture	-149%	-199%	-74%	5%	-14%	-4%
Bmk +ve Days	10	22	35	71	142	415
Stock +ve Days	9	18	26	51	105	257
Down Capture	-193%	14%	121%	163%	132%	103%
Bmk -ve Days	11	19	27	54	106	334
Stock -ve Days	10	21	33	68	133	340

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively

Short Interest

Short Interest: As Of Date	9152025
Short Interest: Shares Quantity	17,978
Short Interest: % Change Since 8312025	-51.4%
Average Daily Volume	35,792
Days-to-Cover Short Interest	1
Basic Shares Quantity	9,305,819
Short % of Basic Shares	0.2%

SEC Filings

Expand for More

Report Date	Filing Date	Filing
3312025	7312025	20-F 3/31/2025
9302024	12192024	6-K 9/30/2024
3312024	8152024	20-F 3/31/2024
9302023	1222024	6-K 9/30/2023
6302023	8162023	6-K 6/30/2023
3312023	8152023	424B3 3/31/2023
3312022	2082023	424B3 3/31/2022

Insider Activity

Expand for More

Industry Resources

Health Care Resources

U.S. National Library of Medicine

Health Data Management

FDA Tracker

Biotechnology Resources

Fierce Biotech

Nature Biotechnology

Genetic Engineering & Biotechnology News

Biotechnology Innovation Organization

BioWorld

BioTechniques

HBS Biotechnology Publications

External Quote Links

0	Y Finance	Barrons
1	TradingView	Morningstar
2	SeekingAlpha	ValueLine
3	Motley Fool	Robinhood
4	CNBC	Etrade
5	MarketWatch	Unusual Whales
6	YCharts	Perplexity Finance
7	FinViz

Prefer one of these to Trefis? Tell us why.

LakeShore Biopharma (LSB)

Market Price (9/30/2025): $0.4919 | Market Cap: $4.6 MilSector: Health Care | Industry: Biotechnology

LakeShore Biopharma (LSB)

Market Price (9/30/2025): $0.4919Market Cap: $4.6 MilSector: Health CareIndustry: Biotechnology

Investment Highlights

Market Valuation

Business Description

Price Returns Compared

Interactive Breakdown

Better Bets than LakeShore Biopharma (LSB)

Latest Trefis Analyses

Trade Ideas

Recent Active Movers

1 Day Top Gainers

1 Day Top Losers

1 Week Top Gainers

1 Week Top Losers

1 Month Top Gainers

1 Month Top Losers

Recent Active Movers

1 Day Top Gainers

1 Day Top Losers

1 Week Top Gainers

1 Week Top Losers

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for LakeShore Biopharma

Financials

Growth & Margins

Valuation

Returns

Comparison Analyses

FDIC Bank Data

Bank Capital

Bank Deposits

Bank Assets

Bank Loans

Financials

Segment Financials

Price Behavior

Short Interest

Returns Analyses

Earnings Returns History

SEC Filings

Insider Activity

Industry Resources

External Quote Links

Market Price (9/30/2025): $0.4919 | Market Cap: $4.6 Mil
Sector: Health Care | Industry: Biotechnology

Market Price (9/30/2025): $0.4919
Market Cap: $4.6 Mil
Sector: Health Care
Industry: Biotechnology